These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 4057076)

  • 1. Clonidine effects on sulfobromophthalein disposition in mice.
    Ben-Zvi Z; Hurwitz A
    J Pharmacol Exp Ther; 1985 Nov; 235(2):393-7. PubMed ID: 4057076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid effects on hepatic disposition of dyes in mice.
    Hurwitz A; Fischer HR; Innis JD; Ronsse S; Ben-Zvi Z
    J Pharmacol Exp Ther; 1985 Mar; 232(3):617-23. PubMed ID: 3973820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of sulfobromophthalein (BSP) and sulfobromophthalein glutathione (BSP-GSH) disposition under conditions of altered liver function and in the isolated perfused rat liver.
    Yam J; Reeves M; Roberts RJ
    J Lab Clin Med; 1976 Mar; 87(3):373-83. PubMed ID: 1249471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Narcotic effects on hepatic disposition of sulfobromophthalein in rats.
    Hurwitz A; Fischer HR
    J Pharmacol Exp Ther; 1983 Oct; 227(1):68-72. PubMed ID: 6620173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of clonidine and IBMX on sulfobromophthalein disposition in rats.
    Agbaria R; Hurwitz A; Ben-Zvi Z
    Eur J Drug Metab Pharmacokinet; 1993; 18(3):239-45. PubMed ID: 7512026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of cholic acid and dehydrocholic acid on the biliary excretion of unconjugated and conjugated sulfobromophthalein in rats.
    Schulze PJ; Czok G; Meyer H
    Arzneimittelforschung; 1976; 26(10):1894-903. PubMed ID: 1037210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of morphine and clonidine on sulphobromophthalein disposition in mice.
    Ben-Zvi Z; Hurwitz A
    J Pharm Pharmacol; 1986 Jun; 38(6):481-3. PubMed ID: 2873230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic transport of sulphobromphthalein and sulphobromphthalein-glutathione conjugate in control and phenobarbital-pretreated rats.
    Fischer E; Gregus Z; Gógl A
    Acta Physiol Acad Sci Hung; 1978; 51(1-2):61-6. PubMed ID: 754472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of pretreatment with phenobarbital (PB) and sulfobromophthalein (BSP) on the metabolism and the biliary excretion of BSP in the rat.
    Schulze PJ; Czok G; Keller E
    Arzneimittelforschung; 1979; 29(10):1521-8. PubMed ID: 583215
    [No Abstract]   [Full Text] [Related]  

  • 10. Localization of glutathione conjugation activities toward bromosulfophthalein in perfused rat liver. Studies with the multiple indicator dilution technique.
    Zhao Y; Snel CA; Mulder GJ; Pang KS
    Drug Metab Dispos; 1993; 21(6):1070-8. PubMed ID: 7905386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impairment of hepatic glutathione S-transferase activity as a cause of reduced biliary sulfobromophthalein excretion in clofibrate-treated rats.
    Foliot A; Touchard D; Celier C
    Biochem Pharmacol; 1984 Sep; 33(18):2829-34. PubMed ID: 6477642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental value of the biliary excretion of the conjugated form of SBP by the in vivo liver and by the isolated and perfused liver].
    Catau G; Catau R; Besson S; Galipienso AM
    C R Seances Soc Biol Fil; 1975; 169(3):637-40. PubMed ID: 129212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the enzymatic activity of ligandin by organogermanium, organolead or organotin compounds and the biliary excretion of sulfobromophthalein by the rat.
    Byington KH; Hansbrough E
    J Pharmacol Exp Ther; 1979 Feb; 208(2):248-53. PubMed ID: 762656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonidine effects on disposition of xenobiotics in rats: inhibited elimination of flow-limited but not extraction-limited agents.
    Ben-Zvi Z; Hurwitz A
    Br J Pharmacol; 1988 May; 94(1):97-102. PubMed ID: 3401645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impairment of sulfobromophthalein biliary excretion and inhibition of glutathione S-transferase activity induced by perhexiline maleate in rats.
    Mariscal MA; Muñoz ME; Collado PS; Esteller A; Gonzalez J
    Biochem Pharmacol; 1988 Sep; 37(18):3461-5. PubMed ID: 3421996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerance to effects of clonidine and morphine on sulfobromophthalein disposition in mice.
    Ben-Zvi Z; Graham CE; Hurwitz A
    Life Sci; 1987 Apr; 40(16):1617-23. PubMed ID: 3561168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biliary excretion of dye in dogs infused with BSP or its glutathione conjugate.
    Barnhart JL; Combes B
    Am J Physiol; 1976 Aug; 231(2):399-407. PubMed ID: 961890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Qualitative differences in the hepatobiliary transport of sulfobromophthalein (BSP) and its glutathione conjugate (BSP-GSH).
    Gregus Z; Fischer E
    Acta Med Acad Sci Hung; 1980; 37(3):315-20. PubMed ID: 6161515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma disappearance and biliary excretion of bromosulfophthalein in styrene-treated and styrene oxide-treated rats.
    Chakrabarti S; Brodeur J
    J Toxicol Environ Health; 1981 Oct; 8(4):609-17. PubMed ID: 7338933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excretion of sulfobromophthalein in rats with iodomethane-induced depletion of hepatic glutathione.
    Schulze PJ; Czok G; Borck HU
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Dec; 296(1):79-85. PubMed ID: 1012349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.